Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.

Harney BL, Sacks-Davis R, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS

Global Infectious Disease Threats Hepatitis C HIV + AIDS

I know what you did last summer: a cross-sectional study of personal COVID-19 risk reduction strategies used by Victorian adults, December 2021-January 2022.

Tse WC, Altermatt A, Saich F, Wilkinson AL, Heath K, Young K, Pedrana A, Hill S, Gibbs L, Stoové M, Gibney KB, Hellard M

COVID-19

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia.

Aung PTZ, Spelman T, Wilkinson AL, Dietze PM, Stoové MA, Hellard ME

Hepatitis C Injecting Drug Use

The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.

Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, Doyle JS, Hellard M, Wilkinson A, Quinn B, Crawford S, Sutton K, Dietze P

COVID-19

Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia.

Nguyen T, Thomas AJ, Kerr P, Stewart AC, Wilkinson AL, Nguyen L, Altermatt A, Young K, Heath K, Bowring A, Fletcher-Lartey S, Lusher D, Hill S, Pedrana A, Stoové M, Gibney K, Hellard M

COVID-19

Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia.

Curtis M, Wilkinson AL, Dietze P, Stewart AC, Kinner SA, Cossar RD, Nehme E, Aitken C, Walker S, Butler T, Winter RJ, Smith K, Stoove M